A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has ...

They work by exploiting the interactions between antibodies and their target antigens, making them crucial in applications ...

By these arrangements, each of the two arms of the antibody includes one light chain and one heavy chain, with the variable regions at the tips of the Y arms defining antigen specificity.

Researchers uncover how the skin autonomously produces antibodies through specialized immune structures, maintaining ...

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.

A research team led by Prof. Wang Haoyi from the Institute of Zoology (IOZ) of the Chinese Academy of Sciences has developed ...

To generate polyclonal antibodies, laboratory animals are injected with the antigen of interest and, in a few weeks (with luck), one obtains antibodies that recognize the antigen with high ...

Favourable safety profile for world’s first LAG-3 agonist, IMP761, with no treatment related adverse events to dateAdditional safety data and ...

Cibisatamab is a monoclonal antibody commercialized by Roche, with a leading Phase II program in Squamous Non-Small Cell Lung Cancer.

In addition to targeting a specific tumor protein, the treatment includes a bispecific antibody that enhances the therapeutic ...

A clinical abstract on the induction results from the CoTikiS Phase 2 trial of anti-IL-7 Receptor Lusvertikimab in Ulcerative ...

Future Virology. 2013;8(11):1127-1134. Breast milk contains high concentration of secretory antibodies, mainly IgA, with a broad range of specificities reflecting both maternal immunologic memory ...